Yang Weizhu

772 total citations
25 papers, 232 citations indexed

About

Yang Weizhu is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yang Weizhu has authored 25 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Yang Weizhu's work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver physiology and pathology (4 papers) and Vascular Procedures and Complications (4 papers). Yang Weizhu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver physiology and pathology (4 papers) and Vascular Procedures and Complications (4 papers). Yang Weizhu collaborates with scholars based in China, United States and Türkiye. Yang Weizhu's co-authors include Jingyao Huang, Ning Huang, Na Jiang, Kun Ke, Quan Shen, Hui Zheng, Jian‐Jun Li, Zhengzhong Wu, Naijian Ge and Zhi‐Cheng Jin and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Immunology and World Journal of Gastroenterology.

In The Last Decade

Yang Weizhu

23 papers receiving 230 citations

Peers

Yang Weizhu

HEPAT

PRM

EPIDE

SURGE

ONCOL

S Schulte Germany

Tim A. Labeur Netherlands

Giulia Magini Italy

J. Boese-Landgraf Germany

Vikas Ostwal India

Kenichiro Kodama Japan

Takayuki Fukuhara Japan

Piotr Spychalski Poland

Eric Zerbib France

Naoki Kamachi Japan

S Schulte Germany

Yang Weizhu

121 ×0.9

HEPAT

98 ×1.4

PRM

102 ×1.6

EPIDE

168 ×3.1

SURGE

67 ×1.6

ONCOL

Citations per year, relative to Yang Weizhu Yang Weizhu (= 1×) peers S Schulte

Countries citing papers authored by Yang Weizhu

Since Specialization

Citations

This map shows the geographic impact of Yang Weizhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Weizhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Weizhu more than expected).

Fields of papers citing papers by Yang Weizhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Weizhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Weizhu. The network helps show where Yang Weizhu may publish in the future.

Co-authorship network of co-authors of Yang Weizhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Weizhu. A scholar is included among the top collaborators of Yang Weizhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Weizhu. Yang Weizhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Han, Kun Ke, Zhengzhong Wu, et al.. (2024). Three-dimensional treatment-planning-based prediction of seed migration to chest after 125I seed brachytherapy for hepatic malignancy. Brachytherapy. 23(4). 478–488.

Ke, Kun, et al.. (2024). Safety and efficacy of biliary stenting combined with iodine-125 seed strand followed by hepatic artery infusion chemotherapy plus lenvatinib with PD-1 inhibitor for the treatment of extrahepatic cholangiocarcinoma with malignant obstructive jaundice. Frontiers in Immunology. 14. 1286771–1286771. 3 indexed citations

Teng, Gao‐Jun, Hao Xu, Zhen Li, et al.. (2024). Efficacy and safety of a novel vena cava filter on pulmonary embolism prophylaxis: a prospective, multicenter, randomized, parallel, positive-controlled, noninferiority clinical trial. Quantitative Imaging in Medicine and Surgery. 14(10). 7073–7085.

Ke, Kun, et al.. (2023). Increased Expression of CD74 in Atherosclerosis Associated with Inflammatory Responses of Endothelial Cells and Macrophages. Biochemical Genetics. 62(1). 294–310. 3 indexed citations

Zheng, Hui, et al.. (2023). Effect and mechanism of pirfenidone combined with 2-methoxy-estradiol perfusion through portal vein on hepatic artery hypoxia-induced hepatic fibrosis. Advances in Medical Sciences. 68(1). 46–53. 4 indexed citations

Jin, Zhi‐Cheng, Bin‐Yan Zhong, Jian-Jia Chen, et al.. (2023). Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study. European Radiology. 33(12). 8669–8681. 49 indexed citations

Ke, Kun, et al.. (2023). Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis. Brachytherapy. 22(6). 858–871. 7 indexed citations

Ke, Kun, et al.. (2022). A meta-analysis comparing hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma. Translational Cancer Research. 11(1). 99–112. 7 indexed citations

Zheng, Hui, Yang Weizhu, Kun Ke, & Jingyao Huang. (2020). Endovascular Repair of Spontaneous Iliac Vein Rupture. Annals of Vascular Surgery. 73. 510.e25–510.e28. 5 indexed citations

10.

Chen, Lihong, et al.. (2020). A novel combination of percutaneous stenting with iodine-125 seed implantation and chemotherapy for the treatment of pancreatic head cancer with obstructive jaundice. Brachytherapy. 20(1). 218–225. 9 indexed citations

11.

Lin, Wei‐Wen, et al.. (2019). Hippocampal atrophy and functional connectivity disruption in cirrhotic patients with minimal hepatic encephalopathy. Metabolic Brain Disease. 34(6). 1519–1529. 14 indexed citations

12.

Jiang, Han, Yang Weizhu, Na Jiang, et al.. (2018). Predictive factors of benefit from iodine-125 brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis. Brachytherapy. 18(2). 233–239. 10 indexed citations

13.

Weizhu, Yang, Na Jiang, Jingyao Huang, et al.. (2017). Incidence and prediction of seed migration to the chest after iodine-125 brachytherapy for hepatocellular carcinoma. Brachytherapy. 16(6). 1252–1256. 4 indexed citations

14.

Weizhu, Yang, et al.. (2016). The utilization of hardening agent for the treatment of cephalocervical venous malformations: study of its clinical efficacy and mechanism. 25(12). 1053. 1 indexed citations

15.

Ke, Kun, Hui Zheng, & Yang Weizhu. (2016). Is Multilayer Bare Stent Safe or Effective for the Treatment of Aortic Aneurysms? A Meta-analysis with Early and Mid-term Outcomes. Annals of Vascular Surgery. 40. 112–119. 10 indexed citations

16.

Huang, Ning, et al.. (2013). Application of Guglielmi Detachable Coils in Embolization of Iatrogenic Renal Hemorrhage. Annals of Vascular Surgery. 27(8). 1081–1087. 2 indexed citations

17.

Weizhu, Yang, et al.. (2009). Combined therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation for small hepatocellular carcinoma. World Journal of Gastroenterology. 15(6). 748–748. 32 indexed citations

18.

Weizhu, Yang, Qun Hu, Jing Ma, et al.. (2006). Solid phase extraction and spectrophotometric determination of mercury in tobacco and tobacco additives with 5-(p-aminobenzylidene)-thiothiorhodanine. Journal of the Brazilian Chemical Society. 17(5). 1039–1044. 13 indexed citations

19.

Weizhu, Yang, et al.. (2006). Treatment of portal vein tumor emboli of hepatocellular carcinoma with CT-guided percutaneous ethanol injection. Journal of interventional radiology. 15(11). 670–672. 1 indexed citations

20.

Huang, Jingyao, et al.. (2006). Portal vein embolization induces compensatory hypertrophy of remnant liver. World Journal of Gastroenterology. 12(3). 408–408. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact